X4 Pharmaceuticals Inc (NASDAQ: XFOR) kicked off on Friday, down -1.32% from the previous trading day, before settling in for the closing price of $0.75. Over the past 52 weeks, XFOR has traded in a range of $0.26-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -25.00% over the past five years. While this was happening, its average annual earnings per share was recorded 77.49%. With a float of $117.85 million, this company’s outstanding shares have now reached $168.51 million.
Let’s look at the performance matrix of the company that is accounted for 93 employees. In terms of profitability, gross margin is 85.2%, operating margin of -618.81%, and the pretax margin is -398.61%.
X4 Pharmaceuticals Inc (XFOR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 30.90%, while institutional ownership is 35.60%. The most recent insider transaction that took place on Nov 15 ’24, was worth 12,583. In this transaction President and CEO of this company sold 31,897 shares at a rate of $0.39, taking the stock ownership to the 993,919 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Officer proposed sale 31,897 for $0.41, making the entire transaction worth $13,078.
X4 Pharmaceuticals Inc (XFOR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.49% per share during the next fiscal year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Take a look at X4 Pharmaceuticals Inc’s (XFOR) current performance indicators. Last quarter, stock had a quick ratio of 4.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 111.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
X4 Pharmaceuticals Inc (NASDAQ: XFOR) saw its 5-day average volume 2.06 million, a positive change from its year-to-date volume of 1.75 million. As of the previous 9 days, the stock’s Stochastic %D was 58.43%. Additionally, its Average True Range was 0.11.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 75.96%, which indicates a significant increase from 58.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 176.37% in the past 14 days, which was lower than the 180.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5341, while its 200-day Moving Average is $0.7909. Nevertheless, the first resistance level for the watch stands at $0.7831 in the near term. At $0.8240, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8556. If the price goes on to break the first support level at $0.7106, it is likely to go to the next support level at $0.6790. Assuming the price breaks the second support level, the third support level stands at $0.6381.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
The company with the Market Capitalisation of 124.89 million has total of 170,546K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -101,170 K annual income. Company’s last quarter sales were recorded 560 K and last quarter income was -36,700 K.
